BTL Aesthetics Strengthens Its Team of Key Opinion Leaders

With 30 years of innovation and more products set to explode onto the market, BTL aesthetics strengthens its global team of key opinion leaders.

Following the unparalleled success of the recent EMSCULPT NEO® and EMFACE® launches, BTL Aesthetics, the trusted market leader in non-invasive body treatments and a major manufacturer of medical aesthetics equipment, is proud to extend its esteemed team of Global Key Opinion Leaders with the appointment of Dr Sherina Balaratnam.

This is the first time in BTL’s 30-year history that a non-US-based Doctor has been invited to represent BTL Aesthetics as a Global Key Opinion Leader

With over 25 years’ experience as a qualified doctor, Dr Sherina has spent the last 14 years practising within her current specialism of aesthetic medicine. A trusted authority across the aesthetics industry, Dr Sherina owns a multi-award-winning clinic, S-Thetics, in Buckinghamshire, UK.

BTL’s ambition is to accelerate its continued growth on a global scale and the addition of Dr Sherina alongside its other global team of experts will see her insights, research and experience assist the R&D team with future technological development as well as continuing to increase brand awareness and product education. Featuring a number of BTL Aesthetics’ most innovative technologies in her own clinic, including EMSCULPT®, EMSCULPT NEO®, EMSELLA®, and the latest addition, EMFACE®, Dr Sherina is  able to share her deep understanding and knowledge of these treatment protocols, further supported by her strong, proven success rate of delivering expert results in body and facial rejuvenation.

“I am honoured to have been invited to represent BTL in the capacity of Global Key Opinion Leader. We are now in our 5th year of proudly hosting BTL technologies at my clinic, S-Thetics; starting with EMSCULPT®, then progressing to EMSCULPT NEO®, EMSELLA® and now EMFACE® and beyond. My interest and passion in aesthetics is in the field of regenerative science and medicine and, having worked so closely with BTL, I feel a strong alignment in our ethos for patient safety, innovation and enhancing our patients’ outcomes using multiple treatment modalities. Our patients continue to benefit from these best-in-class technologies and treatments, and I am looking forward to working with the BTL family on some exciting new projects.”
Miss (Dr) Sherina Balaratnam MBBS MRCS(Edin) MSc (UCL), Surgeon and Cosmetic Doctor, Medical Director, S-Thetics Clinic

“We are very proud of our track record in R&D and to have our KOLs as a part of the development of BTL devices and technologies – often at the embryonic stages. With their invaluable insights and support, we aim to break new frontiers in aesthetics and exceed the needs and expectations of the aesthetic market and patients alike. BTL's mission is not only to have the best aesthetic results possible but also to put our focus on real, functional medicine which today has become a very important part of aesthetic medicine. Collaborating with the brightest minds in their fields will help us achieve our goals.”

Zbynek Pistak, BTL Managing Director